Stefanie Kaiser is focused on identifying epitranscriptome RNA modifications and understanding their function with the use of neuronal disease models such as ALS and Trmt1-induced mental retardation. With the help of mass spectrometry and biosynthetic isotopic labeling, dynamic processes of RNA modifications are studied allowing to distinguish various mechanisms of RNA modification adaptation and to find new perspective on neuronal diseases.
